Skip to main content
. 2015 Aug 9;14(10):2753–2763. doi: 10.1074/mcp.M115.047928

Table II. Summary of the glycopeptide, AGPN#GTLFVADAYK, with different glycoforms.

Accession Spectra HexNAc Hexose Fucose Sialic Acid Glycopeptide
Global
SPEG
LNCaP/LNCaP PC3/LNCaP LNCaP/LNCaP PC3/LNCaP LNCaP/LNCaP PC3/LNCaP
24308201 1 3 3 1 0 1.46 5.44 0.99 1.02 0.98 1.07
24308201 2 2 3 1 0 1.04 2.37 0.99 1.02 0.98 1.07
24308201 2 4 3 1 0 1.42 7.37 0.99 1.02 0.98 1.07
24308201 1 2 5 1 0 1.14 4.33 0.99 1.02 0.98 1.07
24308201 2 5 3 1 0 1.09 8.47 0.99 1.02 0.98 1.07
24308201 5 2 5 0 0 1.17 0.74 0.99 1.02 0.98 1.07
24308201 5 2 6 0 0 1.09 0.39 0.99 1.02 0.98 1.07
24308201 2 2 8 0 0 0.94 0.51 0.99 1.02 0.98 1.07
24308201 2 2 9 0 0 1.48 0.48 0.99 1.02 0.98 1.07
24308201 1 2 7 0 0 1.12 0.94 0.99 1.02 0.98 1.07
HHS Vulnerability Disclosure